Literature DB >> 29518718

Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling.

Huiyuan Zhao1, Cui Wang2, Nan Zhao1, Wenxue Li3, Zhaofei Yang4, Xinxin Liu1, Weidong Le5, Xiaozhe Zhang6.   

Abstract

The plasma of Parkinson's disease (PD) patients may contain various altered metabolites associated with the risk or progression of the disease. Characterization of the abnormal metabolic pattern in PD plasma is therefore critical for the search for potential PD biomarkers. We collected blood plasma samples from PD patients and used an LC-MS based metabolomics approach to identify 17 metabolites with significantly altered levels. Metabolic network analysis was performed to place the metabolites linked to different pathways. The metabolic pathways involved were associated with tyrosine biosynthesis, glycerol phospholipid metabolism, carnitine metabolism and bile acid biosynthesis, within which carnitine and bile acid metabolites as potential biomarkers are first time reported. These abnormal metabolic changes in the plasma of patients with PD were mainly related to lipid metabolism and mitochondrial function.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Metabolites; Metabolomics; Parkinson's disease; Pathway; Plasma

Mesh:

Substances:

Year:  2018        PMID: 29518718     DOI: 10.1016/j.jchromb.2018.01.025

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  19 in total

1.  Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson's Disease: Focus on Neuroinflammation.

Authors:  Bruno L Santos-Lobato; Luiz Gustavo Gardinassi; Mariza Bortolanza; Ana Paula Ferranti Peti; Ângela V Pimentel; Lúcia Helena Faccioli; Elaine A Del-Bel; Vitor Tumas
Journal:  Mol Neurobiol       Date:  2021-12-02       Impact factor: 5.590

Review 2.  Review of Metabolomics-Based Biomarker Research for Parkinson's Disease.

Authors:  Xin Li; Xiaoying Fan; Hongtian Yang; Yufeng Liu
Journal:  Mol Neurobiol       Date:  2021-11-26       Impact factor: 5.590

Review 3.  Alpha-Synuclein as a Biomarker of Parkinson's Disease: Good, but Not Good Enough.

Authors:  Upasana Ganguly; Sukhpal Singh; Soumya Pal; Suvarna Prasad; Bimal K Agrawal; Reena V Saini; Sasanka Chakrabarti
Journal:  Front Aging Neurosci       Date:  2021-07-08       Impact factor: 5.750

Review 4.  The Role of Lipids in Parkinson's Disease.

Authors:  Helena Xicoy; Bé Wieringa; Gerard J M Martens
Journal:  Cells       Date:  2019-01-07       Impact factor: 6.600

5.  Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson's Disease.

Authors:  Sebastiaan P van Kessel; Sahar El Aidy
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

6.  Metabolic profiling reveals dysregulated lipid metabolism and potential biomarkers associated with the development and progression of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).

Authors:  Marwa Zafarullah; Grzegorz Palczewski; Susan M Rivera; David R Hessl; Flora Tassone
Journal:  FASEB J       Date:  2020-11-01       Impact factor: 5.191

Review 7.  Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.

Authors:  Yixuan Liang; Li Cui; Jiguo Gao; Mingqin Zhu; Ying Zhang; Hong-Liang Zhang
Journal:  Mol Neurobiol       Date:  2021-04-06       Impact factor: 5.590

8.  Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.

Authors:  Jay S Schneider
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

Review 9.  Metabolic Alterations in FMR1 Premutation Carriers.

Authors:  Yiqu Cao; Yun Peng; Ha Eun Kong; Emily G Allen; Peng Jin
Journal:  Front Mol Biosci       Date:  2020-09-18

10.  Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease.

Authors:  Sarah Vascellari; Vanessa Palmas; Marta Melis; Silvia Pisanu; Roberto Cusano; Paolo Uva; Daniela Perra; Veronica Madau; Marianna Sarchioto; Valentina Oppo; Nicola Simola; Micaela Morelli; Maria Laura Santoru; Luigi Atzori; Maurizio Melis; Giovanni Cossu; Aldo Manzin
Journal:  mSystems       Date:  2020-09-15       Impact factor: 6.496

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.